GOSS
Price
$3.20
Change
+$0.02 (+0.63%)
Updated
Sep 16, 04:59 PM (EDT)
Capitalization
727.62M
51 days until earnings call
WHWK
Price
$1.96
Change
+$0.10 (+5.38%)
Updated
Sep 16, 04:59 PM (EDT)
Capitalization
91.9M
50 days until earnings call
Interact to see
Advertisement

GOSS vs WHWK

Header iconGOSS vs WHWK Comparison
Open Charts GOSS vs WHWKBanner chart's image
Gossamer Bio
Price$3.20
Change+$0.02 (+0.63%)
Volume$122.5K
Capitalization727.62M
Whitehawk Therapeutics
Price$1.96
Change+$0.10 (+5.38%)
Volume$200
Capitalization91.9M
GOSS vs WHWK Comparison Chart in %
Loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GOSS vs. WHWK commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Buy and WHWK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 17, 2025
Stock price -- (GOSS: $3.20 vs. WHWK: $1.95)
Brand notoriety: GOSS and WHWK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 91% vs. WHWK: 92%
Market capitalization -- GOSS: $727.62M vs. WHWK: $91.9M
GOSS [@Biotechnology] is valued at $727.62M. WHWK’s [@Biotechnology] market capitalization is $91.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileWHWK’s FA Score has 0 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • WHWK’s FA Score: 0 green, 5 red.
According to our system of comparison, WHWK is a better buy in the long-term than GOSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 4 TA indicator(s) are bullish while WHWK’s TA Score has 5 bullish TA indicator(s).

  • GOSS’s TA Score: 4 bullish, 4 bearish.
  • WHWK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both GOSS and WHWK are a good buy in the short-term.

Price Growth

GOSS (@Biotechnology) experienced а +15.52% price change this week, while WHWK (@Biotechnology) price change was +8.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.37%. For the same industry, the average monthly price growth was +6.95%, and the average quarterly price growth was +36.10%.

Reported Earning Dates

GOSS is expected to report earnings on Nov 06, 2025.

WHWK is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+3.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GOSS($728M) has a higher market cap than WHWK($91.9M). GOSS YTD gains are higher at: 253.748 vs. WHWK (-38.193). WHWK has higher annual earnings (EBITDA): -10.21M vs. GOSS (-128.6M). GOSS has more cash in the bank: 213M vs. WHWK (177M). WHWK has less debt than GOSS: WHWK (0) vs GOSS (203M). GOSS has higher revenues than WHWK: GOSS (40.2M) vs WHWK (21.6M).
GOSSWHWKGOSS / WHWK
Capitalization728M91.9M792%
EBITDA-128.6M-10.21M1,259%
Gain YTD253.748-38.193-664%
P/E RatioN/A11.67-
Revenue40.2M21.6M186%
Total Cash213M177M120%
Total Debt203M0-
FUNDAMENTALS RATINGS
GOSS vs WHWK: Fundamental Ratings
GOSS
WHWK
OUTLOOK RATING
1..100
2518
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
38
Fair valued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
3449
P/E GROWTH RATING
1..100
10043
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WHWK's Valuation (38) in the Pharmaceuticals Major industry is in the same range as GOSS (55). This means that WHWK’s stock grew similarly to GOSS’s over the last 12 months.

WHWK's Profit vs Risk Rating (98) in the Pharmaceuticals Major industry is in the same range as GOSS (100). This means that WHWK’s stock grew similarly to GOSS’s over the last 12 months.

WHWK's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as GOSS (100). This means that WHWK’s stock grew similarly to GOSS’s over the last 12 months.

GOSS's Price Growth Rating (34) in the Pharmaceuticals Major industry is in the same range as WHWK (49). This means that GOSS’s stock grew similarly to WHWK’s over the last 12 months.

WHWK's P/E Growth Rating (43) in the Pharmaceuticals Major industry is somewhat better than the same rating for GOSS (100). This means that WHWK’s stock grew somewhat faster than GOSS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GOSSWHWK
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 15 days ago
78%
Declines
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WHWK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEIGY3.950.25
+6.76%
Semperit Ag Holding
HRBR0.530.03
+6.00%
Harbor Diversified, Inc.
BVNRY12.240.08
+0.63%
Bavarian Nordic A/S
CPAMF1.84N/A
N/A
CAPITALAND INTEGRATED COML TR MGMT LTD
RTON0.02N/A
N/A
Right On Brands, Inc.

GOSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with LITS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then LITS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
+0.63%
LITS - GOSS
46%
Loosely correlated
-7.56%
APVO - GOSS
41%
Loosely correlated
+4.17%
ABEO - GOSS
39%
Loosely correlated
-0.79%
AUPH - GOSS
37%
Loosely correlated
-2.26%
SLDB - GOSS
37%
Loosely correlated
-1.46%
More

WHWK and

Correlation & Price change

A.I.dvisor indicates that over the last year, WHWK has been loosely correlated with DMAC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if WHWK jumps, then DMAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WHWK
1D Price
Change %
WHWK100%
+4.84%
DMAC - WHWK
45%
Loosely correlated
-0.57%
AXON - WHWK
44%
Loosely correlated
-1.33%
AMRN - WHWK
37%
Loosely correlated
N/A
ARRY - WHWK
36%
Loosely correlated
-1.02%
SNDX - WHWK
34%
Loosely correlated
-5.05%
More